Table 3.
The survival probabilities at 1, 2 and 5 years by treatment modality and cohort, from Day 1 of the start of KRT, dialysis or from the day of kidney transplantation
| Survival probabilities as percentage (95% CIs) |
|||||||
|---|---|---|---|---|---|---|---|
| Cohort: 2009–13 | Cohort: 2012–16 | ||||||
| Survival type | 1 year | 2 years | 5 years | 1 year | 2 years | ||
| Patient survival on KRT | |||||||
| Unadjusted | 84.3 (84.2–84.5) | 74.3 (74.2–74.5) | 51.1 (51.0–51.2) | 85.1 (85.0–85.3) | 75.1 (75.0–75.3) | ||
| Adjusteda | 87.0 (86.9–87.2) | 77.9 (77.6–78.1) | 53.1 (52.8–53.4) | 87.5 (87.4–87.7) | 78.3 (78.1–78.5) | ||
| Patient survival on dialysis | |||||||
| Unadjusted | 83.3 (83.1–83.4) | 71.8 (71.7–72.0) | 42.6 (42.5–42.7) | 84.1 (83.9–84.2) | 72.6 (72.4–72.7) | ||
| Adjusteda | 85.5 (85.3–85.6) | 75.1 (74.9–75.3) | 46.4 (46.1–46.8) | 86.3 (86.1–86.5) | 76.0 (75.8–76.3) | ||
| Patient survival after first kidney transplantation (deceased donor) | |||||||
| Unadjusted | 96.1 (95.9–96.3) | 94.0 (93.8–94.2) | 86.6 (86.3–86.9) | 96.3 (96.1–96.4) | 94.1 (93.9–94.3) | ||
| Adjustedb | 97.8 (97.7–97.9) | 96.5 (96.4–96.7) | 92.0 (91.7–92.3) | 98.0 (97.8–98.1) | 96.8 (96.6–96.9) | ||
| Graft survival after first kidney transplantation (deceased donor) | |||||||
| Unadjusted | 90.7 (90.5–91.0) | 87.6 (87.3–87.9) | 77.5 (77.2–77.9) | 91.2 (90.9–91.4) | 88.0 (87.7–88.3) | ||
| Adjustedb | 92.4 (92.1–92.6) | 89.7 (89.4–90.0) | 81.1 (80.6–81.5) | 93.0 (92.7–93.2) | 90.4 (90.1–90.7) | ||
| Patient survival after first kidney transplantation (living donor) | |||||||
| Unadjusted | 98.9 (98.7–99.1) | 97.9 (97.6–98.2) | 93.9 (93.5–94.3) | 98.9 (98.7–99.1) | 98.0 (97.8–98.3) | ||
| Adjustedb | 99.1 (98.9–99.2) | 98.2 (98.0–98.5) | 94.7 (94.3–95.2) | 99.1 (98.9–99.2) | 98.3 (98.1–98.5) | ||
| Graft survival after first kidney transplantation (living donor) | |||||||
| Unadjusted | 96.5 (96.2–96.8) | 94.7 (94.3–95.1) | 87.8 (87.2–88.3) | 96.7 (96.4–97.0) | 95.1 (94.8–95.5) | ||
| Adjustedb | 96.3 (95.9–96.6) | 94.4 (94.0–94.9) | 87.1 (86.4–87.8) | 96.5 (96.2–96.8) | 94.8 (94.4–95.2) | ||
The findings are based on data from the following renal registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Bosnia and Herzegovina, Denmark, Finland, France, Greece, Iceland, Norway, Spain (Andalusia), Spain (Aragon), Spain (Asturias), Spain (Basque country), Spain (Cantabria), Spain (Castile and León), Spain (Castile-La Mancha), Spain (Catalonia), Spain (Community of Madrid), Spain (Extremadura), Spain (Galicia), Spain (Valencian region), Sweden, the Netherlands, UK (England/Northern Ireland/Wales) and UK (Scotland). Unadjusted survival probabilities were calculated using the Kaplan–Meier method, and adjusted survival probabilities using the Cox regression model.
Analyses were adjusted using fixed values: age (67 years), sex (63% men) and cause of kidney failure (24% DM, 19% hypertension/renal vascular disease, 11% glomerulonephritis and 46% other causes).
Analyses were adjusted using fixed values: age (50 years), sex (63% men) and cause of kidney failure (14% DM, 10% hypertension/renal vascular disease, 23% glomerulonephritis and 53% other causes).